Human Fibroblast Growth Factor 19 (FGF19) Protein

Este producto es parte de FGF19 - Fibroblast Growth Factor 19
Product Graph
234€ (5 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Fibroblast Growth Factor 19 (FGF19) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx262135
tested applications
SDS-PAGE

Description

Fibroblast Growth Factor 19 (FGF19) His Tag Protein is a recombinant cytokine.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryProteins and Peptides
Immunogen TargetFibroblast Growth Factor 19 (FGF19)
HostE. coli
OriginHuman
ConjugationUnconjugated
Observed MWMolecular Weight: 23 kDa Tag: N-terminal His tag
ExpressionRecombinant
Purity> 95% (SDS-PAGE)
PurificationPurified by proprietary chromatographic techniques, followed by filtration (0.4 µm).
Size 15 µg
Size 225 µg
Size 31 mg
FormLyophilized Reconstitute in distilled water to a concentration of approximately 0.5 mg/ml. Allow the lyophilized pellet to dissolve completely before use. Sterile filtration is recommended prior to use in cell culture.
Tested ApplicationsSDS-PAGE
BufferPrior to lyophilization: 20 mM Tris, 20 mM NaCl, pH 7.5.
AvailabilityShipped within 5-10 working days.
StorageStable at room temperature for up to 3 weeks. Store below -18 °C for long-term storage. Upon reconstitution, store at 4 °C for up to 7 days and store below -18 °C for long-term storage. For long-term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDO95750
Gene ID9965
OMIM603891
AliasFGF-19
BackgroundProtein FGF19
StatusRUO
NoteThis product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

FGF19 is a metabolic hormone primarily produced in the ileum of the small intestine in response to bile acid signaling where it regulates bile acid homeostasis by suppressing cholesterol 7α-hydroxylase (CYP7A1) expression in the liver FGF19 also promotes glucose metabolism, lipid homeostasis, and energy expenditure through signaling pathways involving its receptor FGFR4 and the co-receptor β-Klotho Dysregulation of FGF19 has been linked to non-alcoholic fatty liver disease (NAFLD), insulin resistance, and obesity Elevated FGF19 levels are also observed in liver cancers such as hepatocellular carcinoma (HCC) where its overactivation promotes tumor growth by driving cell proliferation and survival FGF19 analogs are being explored as therapies for metabolic disorders, including type 2 diabetes and dyslipidemia

Related Products

EH0129

Human FGF19 (Fibroblast growth factor 19) ELISA Kit

Ver Producto
EP0241

Porcine FGF19(Fibroblast growth factor 19) ELISA Kit

Ver Producto
ER0949

Rat FGF19(Fibroblast Growth Factor 19) ELISA Kit

Ver Producto